Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies

Experimental Cell Research

Volumn 271, Issue 2, 2001, Pages 286-295

  Engelhardt, Othmar G ^a   Ullrich, Evelyn ^a   Kochs, Georg ^a   Haller, Otto ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Mx; PML nuclear bodies; Sumo; Yeast two hybrid system

Indexed keywords

CELL PROTEIN; DAXX PROTEIN; GUANOSINE TRIPHOSPHATASE; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN; NUCLEAR FACTOR; PROMYELOCYTIC LEUKEMIA PROTEIN; PROTEIN BLM; PROTEIN SP100; SUMO 1 PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL FUNCTION; CELL NUCLEUS INCLUSION BODY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ACTIVATION; INFLUENZA VIRUS; NONHUMAN; ORTHOMYXOVIRUS; PRIORITY JOURNAL; PROTEIN INTERACTION; TWO HYBRID SYSTEM;

INFLUENZA VIRUS; MURINAE; ORTHOMYXOVIRIDAE; THOGOTO VIRUS;

EID: 0035842439     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2001.5380     Document Type: Article

References (94)

1. Interferons: Cell signalling, immune modulation, antiviral response and virus countermeasures
2. Mx proteins: Mediators of innate resistance to RNA viruses
3. Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids
4. GTP-bound human MxA protein interacts with the nucleocapsids of Thogoto virus (Orthomyxoviridae)
5. Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses
6. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle
7. Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein
8. Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus
9. Tick-borne Thogoto virus infection in mice is inhibited by the orthomyxovirus resistance gene product Mx1
10. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies
11. Nuclear bodies: Multifaceted subdomains of the interchromatin space
12. Review: Properties and assembly mechanisms of ND10, PML bodies, or PODs
13. The PML nuclear bodies: Actors or extras?
14. Nuclear dots: Actors on many stages
15. Induction of the PML protein by interferons in normal and APL cells
16. Molecular cloning of a new interferon-induced PML nuclear body-associated protein
17. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML)
18. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis
19. Induction of the pro-myelocytic leukaemia gene by type I and type II interferons
20. The acute promyelocytic leukaemia-associated PML gene is induced by interferon
21. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein
22. Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus
23. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator
24. Nuclear domain 10, the site of DNA virus transcription and replication
25. Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
26. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs)
27. The function of PML in p53-dependent apoptosis
28. Regulation of p53 activity in nuclear bodies by a specific PML isoform
29. The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition
30. Human cytomegalovirus immediate early interaction with host nuclear structures: Definition of an immediate transcript environment
31. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1
32. Formation of herpes simplex virus type 1 replication compartments by transfection: Requirements and localization to nuclear domain 10
33. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies
34. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure
35. The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components
36. An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm
37. Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10
38. SUMO - Nonclassical ubiquitin
39. SUMO, ubiquitin's mysterious cousin
40. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus
41. Role of SUMO-1-modified PML in nuclear body formation
42. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1
43. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1
44. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2
45. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites
46. Transforming yeast with DNA
47. A family of interferon-induced Mx-related mRNAs encodes cytoplasmic and nuclear proteins in rat cells
48. The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures
49. Resistance to influenza virus infection of Mx transgenic mice expressing Mx protein under the control of two constitutive promoters
50. Two versatile eukaryotic vectors permitting epitope tagging, radiolabelling and nuclear localisation of expressed proteins
51. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
52. A recombinant human interferon-alpha B/D hybrid with a broad host-range
53. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: A unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex
54. Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein
55. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis
56. Cloning and characterization of Gu/RH-II binding protein
57. Identification of a novel gene encoding a p53-associated protein
58. Daxx, a novel Fas-binding protein that activates JNK and apoptosis
59. The Pax3-FKHR oncoprotein is unresponsive to the Pax3-associated repressor hDaxx
60. Interphase-specific association of intrinsic centromere protein CENP-C with HDaxx, a death domain-binding protein implicated in Fas-mediated cell death
61. Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase
62. Nuclear structure in normal and Bloom syndrome cells
63. A role for PML and the nuclear body in genomic stability
64. Nuclear dot antigens may specify transcriptional domains in the nucleus
65. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2
66. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex
67. Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1
68. Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex
69. In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2
70. Characterization of a novel serine/threonine kinase associated with nuclear bodies
71. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)
72. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in the t(8; 13)(p11;q12) myeloproliferative syndrome
73. FGFR1 is fused with a novel zinc-finger gene. ZNF198, in the t(8;13) leukaemia/lymphoma syndrome
74. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP
75. A set of proteins interacting with transcription factor Sp1 identified in a two-hybrid screening
76. Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins
77. Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p
78. The ubiquitin-like proteins SMT3 and SUMO-1 are conjugated by the UBC9 E2 enzyme
79. MxA GTPase: Oligomerization and GTP-dependent interaction with viral RNP target structures
80. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein
81. Nuclear redistribution of BRCA1 during viral infection
82. Intracellular localization of proteasomal degradation of a viral antigen
83. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As(2)O(3)-induced PML or PML/retinoic acid receptor alpha degradation
84. Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation
85. Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif
86. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b
87. Bovine papillomavirus E1 protein is sumoylated by the host cell Ubc9 protein
88. The Bloom's syndrome gene product is homologous to RecQ helicases
89. Inhibition of Stat1-mediated gene activation by PIAS1
90. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis
91. Cloning and characterization of hGMEB1, a novel glucocorticoid modulatory element binding protein
92. Two new members of the emerging KDWK family of combinatorial transcription modulators bind as a heterodimer to flexibly spaced PuCGPy half-sites
93. Molecular characterization of Celtix-1, a bromodomain protein interacting with the transcription factor interferon regulatory factor 2